News

ThermoDox is Celsion’s proprietary heat-activated liposomal encapsulation of doxorubicin, used for the treatment of various cancers. The agreement will provide Celsion with non-dilutive financing and the investment necessary

The powdered formulation, which contains myo-inositol (2g), plus folic acid (200mcg), was shown to help support menstrual cycle regularity, ovulation function, as well as support the quality of

The agreement also includes licensing development and commercialization rights for PEG-SN38 (EZN-2208), a Phase II PEGylated version of SN38, in the territory of China. Hisun CEO and chairman

Eylea is approved for sale in the US and Australia for the treatment of neovascular age-related macular degeneration (wet AMD). Under the agreement, Bayer owns the exclusive marketing

The company also posted a net loss of $73,000, or $0.00 per share, compared to net earnings of $143,000, or $0.01 per share, for the same quarter in

The 74mcg once-daily product is indicated for the treatment of both ocular and nasal symptoms associated with seasonal allergic rhinitis and the treatment of nasal symptoms associated with

VIvus will market the product under the brand name Stendra in the US. Mitsubishi Tanabe Pharma has discovered TA-1790 as ED therapy, which is expected to have an

With the termination of the agreement, Aeterna has regained the North American rights to perifosine, in all indications. Aeterna announced the continuation of the ongoing Phase 3 trial

The collaboration will focus on the development, manufacturing and commercialization of biosimilar forms of etanercept and rituximab developed by Coherus. Daiichi president and CEO Joji Nakayama said, "By